P. J. Hotez, M. E. Bottazzi, C. Tseng, B. Zhan, S. Lustigman et al., Calling for rapid development of a safe and effective MERS vaccine, Microbes Infect, vol.16, pp.529-560, 2014.

N. Venkatraman, D. Silman, P. M. Folegatti, and A. Hill, Vaccines against Ebola virus, Vaccine, vol.36, pp.5454-5463, 2018.

A. Gagneux-brunon, F. Lucht, O. Launay, P. Berthelot, and E. Botelho-nevers, Vaccines for healthcare-associated infections: present, future, and expectations, Expert Rev Vaccines, vol.17, pp.421-454, 2018.

, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, General Assembly of the World Medical Association, vol.81, pp.14-22, 2014.

A. M. Mcdonald, R. C. Knight, M. K. Campbell, V. A. Entwistle, A. M. Grant et al., What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies, Trials, vol.7, p.9, 2006.

R. Tramm, K. Daws, and V. Schadewaldt, Clinical trial recruitment--a complex intervention?, J Clin Nurs, vol.22, pp.2436-2479, 2013.

E. M. Cobb, D. C. Singer, and M. M. Davis, Public interest in medical research participation: differences by volunteer status and study type, Clin Transl Sci, vol.7, pp.145-154, 2014.

H. J. Larson, A. De-figueiredo, Z. Xiahong, W. S. Schulz, P. Verger et al., The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey, EBioMedicine, vol.12, pp.295-301, 2016.

R. L. Comis, J. D. Miller, D. D. Colaizzi, and L. G. Kimmel, Physician-Related Factors Involved in Patient Decisions to Enroll Onto Cancer Clinical Trials, J Oncol Pract, vol.5, pp.50-56, 2009.

E. Walsh and A. Sheridan, Factors affecting patient participation in clinical trials in Ireland: A narrative review, Contemp Clin Trials Commun, vol.3, pp.23-31, 2016.

S. J. Lee, L. C. Park, J. Lee, S. Kim, M. K. Choi et al., Unique perception of clinical trials by Korean cancer patients, BMC Cancer, vol.12, p.594, 2012.

A. B. Benson, J. P. Pregler, J. A. Bean, A. W. Rademaker, B. Eshler et al., Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study, J Clin Oncol Off J Am Soc Clin Oncol, vol.9, pp.2067-75, 1991.

K. M. Taylor, R. G. Margolese, and C. L. Soskolne, Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer, N Engl J Med, vol.310, pp.1363-1370, 1984.

D. T. Chen, F. G. Miller, and D. L. Rosenstein, Clinical research and the physician-patient relationship, Ann Intern Med, vol.138, pp.669-72, 2003.

A. R. Baer, M. Michaels, M. J. Good, and L. Schapira, Engaging Referring Physicians in the Clinical Trial Process, J Oncol Pract, vol.8, pp.8-10, 2012.

D. Raheja, E. P. Davila, E. T. Johnson, R. Deovi?, M. Paine et al., Willingness to Participate in Vaccine-Related Clinical Trials among Older Adults, Int J Environ Res Public Health, 2018.

K. Crosson, E. Eisner, C. Brown, T. Maat, and J. , Primary care physicians' attitudes, knowledge, and practices related to cancer clinical trials, J Cancer Educ Off J Am Assoc Cancer Educ, vol.16, pp.188-92, 2001.

M. Michaels, D. 'agostino, T. A. Blakeney, N. Weiss, E. S. Binz-scharf et al., Impact of primary care provider knowledge, attitudes, and beliefs about cancer clinical trials: implications for referral, education and advocacy, J Cancer Educ Off J Am Assoc Cancer Educ, vol.30, pp.152-159, 2015.

Y. Plétan, F. Zannad, P. Jaillon, E. Autret-leca, B. Ch et al., Information du public sur les essais cliniques et la recherche, Thérapie, vol.58, pp.185-96, 2003.

A. Pandiya, Readability and Comprehensibility of Informed Consent Forms for Clinical Trials, Perspect Clin Res, vol.1, pp.98-100, 2010.

D. K. Ziegler, M. C. Mosier, M. Buenaver, and K. Okuyemi, How Much Information About Adverse Effects of Medication Do Patients Want From Physicians?, Arch Intern Med, vol.161, pp.706-719, 2001.

E. Karafillakis, H. J. Larson, and . Consortium, The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations, Vaccine, vol.35, pp.4840-50, 2017.

M. Killian, M. Detoc, P. Berthelot, R. Charles, A. Gagneux-brunon et al., Vaccine hesitancy among general practitioners: evaluation and comparison of their immunisation practice for themselves

, Eur J Clin Microbiol Infect Dis, vol.35, pp.1837-1880, 2016.

. Who-|-immunization, , 2018.

S. Rauch, E. Jasny, K. E. Schmidt, and B. Petsch, New Vaccine Technologies to, Combat Outbreak Situations. Front Immunol, vol.9, 2018.

T. J. Hwang and A. S. Kesselheim, Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size Companies, Health Aff Proj Hope, vol.35, pp.219-245, 2016.

, vaccine | Interventional Studies -List Results -ClinicalTrials, vol.15, 2018.

D. Gouglas, T. Le, T. Henderson, K. Kaloudis, A. Danielsen et al., Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study, Lancet Glob Health, vol.6, issue.18, pp.30346-30348, 2018.

C. A. Van-den-bogert, P. C. Souverein, C. Brekelmans, S. Janssen, G. H. Koëter et al., Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands, J Clin Epidemiol, vol.88, pp.140-147, 2017.

E. M. Cobb, D. C. Singer, and M. M. Davis, Public interest in medical research participation: differences by volunteer status and study type, Clin Transl Sci, vol.7, pp.145-154, 2014.

H. J. Larson, A. De-figueiredo, Z. Xiahong, W. S. Schulz, P. Verger et al., The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey

R. Tramm, K. Daws, and V. Schadewaldt, Clinical trial recruitment--a complex intervention, J Clin Nurs, vol.22, pp.2436-2479, 2013.

S. P. Buchbinder, B. Metch, S. E. Holte, S. Scheer, A. Coletti et al., Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation, J Acquir Immune Defic Syndr, vol.36, pp.604-616, 1999.

M. Detoc, A. Gagneux-brunon, F. Lucht, and E. Botelho-nevers, Barriers and motivations to volunteers' participation in preventive vaccine trials: a systematic review, Expert Rev Vaccines, vol.16, pp.467-77, 2017.

, Welcome to the I-REIVAC website | I-REIVAC -Innovative Clinical Research Network In Vaccinology n, 2019.

L. Harrington, P. Van-damme, C. Vandermeulen, and S. Mali, Recruitment barriers for prophylactic vaccine trials: A study in Belgium, Vaccine, vol.35, pp.6598-603, 2017.

S. Rikin, S. Shea, P. Larussa, and M. Stockwell, Factors associated with willingness to participate in a vaccine clinical trial among elderly Hispanic patients, Contemp Clin Trials Commun, vol.7, p.122, 2017.

E. Shim, G. B. Chapman, J. P. Townsend, and A. P. Galvani, The influence of altruism on influenza vaccination decisions, J R Soc Interface, vol.9, pp.2234-2277, 2012.

S. Ross, A. Grant, C. Counsell, W. Gillespie, I. Russell et al., Barriers to participation in randomised controlled trials: a systematic review, J Clin Epidemiol, vol.52, pp.1143-56, 1999.

B. N. Sojka and P. Sojka, The blood donation experience: self-reported motives and obstacles for donating blood, Vox Sang, vol.94, pp.56-63, 2008.

D. Raheja, E. P. Davila, E. T. Johnson, R. Deovi?, M. Paine et al., Willingness to Participate in Vaccine-Related Clinical Trials among Older Adults, Int J Environ Res Public Health, vol.15, 2018.

L. Costas, J. M. Bayas, B. Serrano, S. Lafuente, and M. Muñoz, Motivations for participating in a clinical trial on an avian influenza vaccine, Trials, vol.13, p.28, 2012.

C. Ervine, Directive 2004/39/Ec of the European Parliament and of the Council of 21

, London: Macmillan Education UK, Core Statut. Co. Law, pp.757-766, 2004.

T. M. Ramsey, J. K. Snyder, L. C. Lovato, C. L. Roumie, S. P. Glasser et al., Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial, Clin Trials Lond Engl, vol.13, pp.319-349, 2016.

P. A. Newman, C. Logie, J. Ll, T. Charles, J. Maxwell et al., Speaking the Dialect": Understanding Public Discourse in the Aftermath of an HIV Vaccine Trial Shutdown, Am J Public Health, vol.101, pp.1749-58, 2011.

P. Benkimoun, Essai clinique mortel de Rennes : un rapport pointe le manque d'information des volontaires, Le Monde.fr, 2016.

O. Yaqub, S. Castle-clarke, N. Sevdalis, and J. Chataway, Attitudes to vaccination: A critical review, Soc Sci Med, vol.112, pp.1-11, 2014.

E. Lazcano-ponce, L. Rivera, E. Arillo-santillán, J. Salmerón, M. Hernández-avila et al., Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Arch Med Res, vol.32, pp.243-250, 2001.

M. Detoc, Proposition d'un essai vaccinal au patient: attitudes du médecin référent RICAI, 2018.

M. Detoc, A. Gagneux-brunon, F. Lucht, and &. E. Botelho-nevers, Barriers and motivations to volunteers' participation in preventive vaccine trials: a systematic review, Expert Review of Vaccines, vol.16, issue.5, pp.467-477, 2017.

M. Detoc, C. Touche, A. Gagneux-brunon, F. Lucht, R. Charles et al., Primary physician's attitudes toward their patients receiving proposal to participate in a vaccine trial Accepté avec révisions mineures dans Human Vaccines and Immunotherapeutics, 2019.

M. Detoc, Barriers and motivations for participation in preventive vaccine clinical trials: experience of 5 clinical research sites Soumis à Vaccine -Avril, 2019.

, Articles en lien avec la vaccination

M. Killian, M. Detoc, P. Berthelot, R. Charles, A. Gagneux-brunon et al., Vaccine hesitancy among general practitioners: evaluation and comparison of their immunisation practice for themselves, their patients and their children, Eur J Clin Microbiol Infect Dis, vol.35, issue.11, pp.1837-1843, 2016.

L. Fanget-sagnes, R. Charles, B. Boyer, P. Berthelot, M. Detoc et al., Vaccins dans la prévention des infections nosocomiales : avis des patients hospitalisés avant pose d'une prothèse orthopédique, Hygiènes, vol.1, pp.21-26, 2019.

A. Gagneux-brunon, P. Morineau-houssine, C. Janssen, V. Ronat, and M. Detoc, Amélie Valran, Solène Secher, François Raffi, Elisabeth Botelho-Nevers Low vaccine Coverage against diphtheria, tetanus, poliomyelitis, invasive pneumococcal diseases and seasonal influenza in French HIV

, Médecins référents : un appui pour améliorer le recrutement dans les essais cliniques vaccinaux

M. Detoc, C. Touche, F. Lucht, A. Gagneux-brunon, and R. Charles, Elisabeth Botelho-Nevers -RICAI 2018 (38 ème réunion inter-disciplinaire de chimiothérapie anti-infectieuse, 2018.

O. Launay, C. Dualé, F. Lucht, and J. Huec, Amandine Gagneux-Brunon -RICAI 2018 (38 ème réunion inter-disciplinaire de chimiothérapie anti-infectieuse, 2018.

, Communications en lien avec la vaccination

N. Maillard, X. Roblin, H. Marotte, and M. Detoc, Elisabeth Botelho-Nevers -Communication orale acceptée aux Journées Nationales d'Infectiologie, 2019.

, AUTRES COMMUNICATIONS

M. Detoc, S. Charaoui, J. Jacquet, M. Ghazi, L. Mery et al., Lisbonne Décembre, 2018.

M. Elyès-ben-khalifa, A. Detoc, J. Lefebvre, S. Huet, D. Titoulet et al., Pascal Vallet -Communication orale acceptée au XXIXe congrès de la Société Française de la Transfusion Sanguine, 2019.

, Vers une écologie du stress en application au don de sang : expérience au sein de l'EFS

M. Elyès-ben-khalifa, A. Detoc, J. Lefebvre, S. Huet, D. Titoulet et al., Pascal Vallet -Communication orale acceptée au XXIXe congrès de la Société Française de la Transfusion Sanguine, 2019.

, Analyse du discours des donneurs : expérience au sein de l'EFS

M. Elyès-ben-khalifa, A. Detoc, J. Lefebvre, S. Huet, D. Titoulet et al., Pascal Vallet -Communication orale acceptée au XXIXe congrès de la Société Française de la Transfusion Sanguine, 2019.

, Le stress lié au don de sang : expérience au sein de l'EFS

M. Elyès-ben-khalifa, A. Detoc, J. Lefebvre, S. Huet, D. Titoulet et al., Pascal Vallet -Communication orale acceptée au XXIXe congrès de la Société Française de la Transfusion Sanguine, 2019.

. Oms-|-vaccination, , 2018.

, World Health Organization. Global Vaccine Action Plan, 2011.

N. Venkatraman, D. Silman, P. M. Folegatti, and A. Hill, Vaccines against Ebola virus, Vaccine, vol.36, pp.5454-5463, 2018.

P. J. Hotez, M. E. Bottazzi, C. Tseng, B. Zhan, S. Lustigman et al., Calling for rapid development of a safe and effective MERS vaccine, Microbes Infect, vol.16, pp.529-560, 2014.

R. Mishra, E. Oviedo-orta, P. Prachi, R. Rappuoli, and F. Bagnoli, Vaccines and antibiotic resistance, Curr Opin Microbiol, vol.15, pp.596-602, 2012.

O. Launay, Vaccines for tomorrow, Médecine, vol.13, pp.142-146, 2017.

, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, General Assembly of the World Medical Association, vol.81, pp.14-22, 2014.

, Attractivité de la France pour la recherche clinique" et sa synthèse n, Essais cliniques : 9ème enquête, vol.15, 2019.

P. Benkimoun, Essai clinique mortel de Rennes : un rapport pointe le manque d'information des volontaires, Le Monde.fr, 2016.

, Essai clinique : j'ai été cobaye pour un médicament, April, vol.15, 2019.

, Essai clinique de Rennes : les cobayes de Biotrial témoignent n.d, vol.15, 2019.

V. L. Shavers, C. F. Lynch, and L. F. Burmeister, Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies, J Natl Med Assoc, vol.92, pp.563-72, 2000.

R. Tramm, K. Daws, and V. Schadewaldt, Clinical trial recruitment--a complex intervention, J Clin Nurs, vol.22, pp.2436-2479, 2013.

A. J. Wakefield, MMR vaccination and autism, Lancet, vol.354, pp.949-50, 1999.

H. Maisonneuve and D. Floret, Wakefield's affair: 12 years of uncertainty whereas no link between autism and MMR vaccine has been proved

, Presse Med, vol.41, pp.827-861, 2012.

G. A. Poland and R. M. Jacobson, Understanding those who do not understand: a brief review of the anti-vaccine movement, Vaccine, vol.19, pp.2440-2445, 2001.

N. E. Macdonald and . Sage-working, Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants, Vaccine, vol.33, pp.4161-4165, 2015.

F. Liard, La crise de confiance : exemple de la grippe, Médecine, vol.13, pp.115-123, 2017.

P. Verger, L. Fressard, F. Collange, A. Gautier, C. Jestin et al., Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France, EBioMedicine, vol.2, pp.891-898, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01816807

H. J. Larson, A. De-figueiredo, Z. Xiahong, W. S. Schulz, P. Verger et al., The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey, EBioMedicine, vol.12, pp.295-301, 2016.

R. Cohen, J. Gaudelus, B. Leboucher, J. Stahl, F. Denis et al., Impact of mandatory vaccination extension on infant vaccine coverages: Promising preliminary results, Med Mal Infect, vol.49, pp.34-41, 2019.

E. M. Cobb, D. C. Singer, and M. M. Davis, Public interest in medical research participation: differences by volunteer status and study type, Clin Transl Sci, vol.7, pp.145-154, 2014.

L. Almeida, B. Azevedo, T. Nunes, M. Vaz-da-silva, and P. Soares-da-silva, Why healthy subjects volunteer for phase I studies and how they perceive their participation?, Eur J Clin Pharmacol, vol.63, pp.1085-94, 2007.

L. Harrington, P. Van-damme, C. Vandermeulen, and S. Mali, Recruitment barriers for prophylactic vaccine trials: A study in Belgium, Vaccine, vol.35, pp.6598-603, 2017.

O. Fillieule and O. Fillieule, Volontaires pour un vaccin ». Les logiques de l'engagement dans les essais vaccinaux ANRS. Cohortes, 1992.

D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement, PLoS Med, vol.6, 2009.

S. Dhalla and G. Poole, Barriers to participation in actual HIV vaccine trials, Curr HIV Res, vol.11, pp.238-283, 2013.

S. Dhalla and G. Poole, Motivators to participation in actual HIV vaccine trials, AIDS Behav, vol.18, pp.263-77, 2014.

A. Hurley-rosenblatt and C. Dorsen, Barriers to Volunteer Enrollment in HIV Preventive Vaccine Clinical Research Trials: A Review of the Literature, Journal of the Association of Nurses in AIDS Care, vol.22, pp.330-334, 2011.

G. L. Freed, S. J. Clark, A. E. Cowan, and M. S. Coleman, Primary care physician perspectives on providing adult vaccines, Vaccine, vol.29, pp.1850-1854, 2011.

R. L. Comis, J. D. Miller, D. D. Colaizzi, and L. G. Kimmel, Physician-Related Factors Involved in Patient Decisions to Enroll Onto Cancer Clinical Trials, J Oncol Pract, vol.5, pp.50-56, 2009.

S. J. Lee, L. C. Park, J. Lee, S. Kim, M. K. Choi et al., Unique perception of clinical trials by Korean cancer patients, BMC Cancer, vol.12, p.594, 2012.

A. B. Benson, J. P. Pregler, J. A. Bean, A. W. Rademaker, B. Eshler et al.,

, Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study, J Clin Oncol, vol.9, pp.2067-75, 1991.

E. Walsh and A. Sheridan, Factors affecting patient participation in clinical trials in Ireland: A narrative review, Contemp Clin Trials Commun, vol.3, pp.23-31, 2016.

D. T. Chen, F. G. Miller, and D. L. Rosenstein, Clinical research and the physician-patient relationship, Ann Intern Med, vol.138, pp.669-72, 2003.

A. Tong, P. Sainsbury, and J. Craig, Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups, Int J Qual Health Care, vol.19, pp.349-57, 2007.

D. K. Ziegler, M. C. Mosier, M. Buenaver, and K. Okuyemi, How Much Information About Adverse Effects of Medication Do Patients Want From Physicians?, Arch Intern Med, vol.161, pp.706-719, 2001.

E. Karafillakis, I. Dinca, F. Apfel, S. Cecconi, A. W?rz et al., Vaccine hesitancy among healthcare workers in Europe: A qualitative study, Vaccine, vol.34, pp.5013-5033, 2016.

N. Agrinier, L. Maréchal, M. Fressard, L. Verger, P. Pulcini et al., Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children, Clinical Microbiology and Infection, vol.23, pp.311-318, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02337094

, Atlas de la Démographie médicale en France, 2018.

P. Verger, F. Collange, L. Fressard, A. Bocquier, A. Gautier et al., Prevalence and correlates of vaccine hesitancy among general practitioners: a cross-sectional telephone survey in France, Euro Surveill, vol.21, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01992999

A. Ferriman, Decline in altruism threatens blood supplies, BMJ, vol.317, p.1405, 1998.

L. Costas, J. M. Bayas, B. Serrano, S. Lafuente, and M. Muñoz, Motivations for participating in a clinical trial on an avian influenza vaccine, Trials, vol.13, p.28, 2012.

O. Yaqub, S. Castle-clarke, N. Sevdalis, and J. Chataway, Attitudes to vaccination: a critical review, Soc Sci Med, vol.112, pp.1-11, 2014.

D. Stacey, F. Légaré, N. F. Col, C. L. Bennett, M. J. Barry et al., Decision aids for people facing health treatment or screening decisions, Cochrane Database Syst Rev, p.1431, 2014.

K. Gillies, S. C. Cotton, J. C. Brehaut, M. C. Politi, and Z. Skea, Decision aids for people considering taking part in clinical trials, Cochrane Database Syst Rev, p.9736, 2015.

I. Juraskova, P. Butow, C. Bonner, M. L. Bell, A. B. Smith et al., Improving decision making about clinical trial participation -a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial, Br J Cancer, vol.111, pp.1-7, 2014.